click below
click below
Normal Size Small Size show me how
Anti-fungal drugs
Mod5 lec1
| Question | Answer |
|---|---|
| methods of susceptibility testing | macro-broth dillution |
| AB biodisk interpretation | flucytosine- almost complete inhibition 95% |
| Automated system for yeast susceptibility | TREK Sensititre YeastOne- microdillution method |
| Technical variables in susceptibility testing | inoculum, media, incubation, end-points |
| Issues with anifungal drugs | solubility, chemical stability, mode of action, partial inhibition, narrow MIC's |
| Five groups of anti-fungal agents | polyenes, azoles, antimetabolites, echinocandins, anti-mitotic |
| polyenes | amphotericin B |
| amphotericin B mode of action | inserts itself into cell membrane by attaching to ergosterol forming pores through which cytoplasm leaks out |
| Azoles | fluconazole, itraconizole, ketoconazole, voriconizole, posiconazole, ravuconizole |
| Azole mode of action | attacks cytochrome enzyme P450 which converts lanosterol to ergostrerol. Cannot synthesize new cell membrane |
| Anti-metabolite | flucytosine |
| Flucytosine mode of action | converts to 5-fluorouracil which inhibits RNA and protein synthesis |
| Echinocandin | caspofungin, micafungin, anidulafungin |
| Eichocandin mode of action | inhibits synthesis of 1,3,B-glucan. Can not form cell wall |
| Anti-mitotic | griseofulvin |
| Griseofulvin mode of action | disrupts mitotic spindle formation |
| Griseofulvin delivery system | taken orally- absorbs in skin layers- as it moves out it disrupts superficial mycotic infection. slow-working/ hepatotoxic |